We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Uplifting Athletes is building a bond between U.S. college football teams and patients who have rare diseases.
CSL Behring in Bern, Switzerland, represents a growing life sciences sector in the European region.
Construction of new CSL headquarters underway in Melbourne.
CSL Behring site includes three labs and cell manufacturing space near leading academic institutions.
Go behind the scenes to see how CSL Behring scientists are working and innovating on campus.
Serving tomorrow’s patient means riding a wave of technology, but don’t forget the human touch.
How we’re integrating AI into our global biotech business
The “Cube” in Marburg will house 600 colleagues upon completion in 2022.
A leader in “disruptive innovation” shares his entrepreneurial journey with CSL Behring staff.
Around the world, CSL is building creative partnerships with universities and research institutions.
Pathogen expert Nathan Roth leads a team that takes a vigilant approach with the medicines patients rely on.
Every Nobel Prize week, we remember CSL Behring’s namesake, named a Nobel laureate in 1901.
Popular search terms:
Americas
Asia Pacific
Europe
